Abstract:Background: Pulmonary thromboembolism (PTE), often arising from deep vein thrombosis, remains a high-mortality condition despite diagnostic advancements. Prognostic models like Pulmonary Embolism Severity Index (PESI) and sPESI identify low-risk groups effectively. The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) score, reflecting nutritional status and systemic inflammation, shows prognostic value in cancers and cardiovascular diseases. This study examines the relationship between in-hospital mortality HALP score and simplified PESI (sPESI) in PTE patients. Methods: This retrospective observational study included patients diagnosed with PTE in the emergency department of a tertiary medical faculty from 2018 to 2023. PTE diagnosis was confirmed via computed tomography pulmonary angiography. Data on transthoracic echocardiography, D-dimer levels, demographics, laboratory results, PESI, sPESI, and HALP scores, and in-hospital mortality were collected. Results: In this study, clinical characteristics of 171 patients with PTE were analysed. The average age was 61.88 ± 19.94 years, and 53.2% were female. Mortality was observed in 19.3% of patients. PESI and sPESI scores were significant predictors of mortality, with area under the curve values of 0.938 and 0.879, respectively. PESI score > 175.50 indicated a significantly higher mortality risk (HR = 18.208; P < .001), while sPESI >2.50 was also a strong predictor (HR = 11.840; P < .001). No significant cut-off value for HALP in predicting mortality was identified. Conclusions: Our study supports the reliability of sPESI and PESI scores in predicting in-hospital mortality in PTE patients. However, the prognostic value of the HALP score requires further investigation. Our findings highlight the need for developing risk stratification models. Key message What is already known on this topic? The PESI and sPESI scores are established prognostic models that effectively identify low-risk groups in patients with PTE. The HALP score, reflecting nutritional status and systemic inflammation, has shown prognostic value in cancer and cardiovascular diseases. What this study adds? This study demonstrates that while PESI and sPESI scores are significant predictors of in-hospital mortality in PTE patients, the HALP score does not have a significant cut-off value for predicting mortality. How this study might affect research, practice, or policy? The findings support the continued use of PESI and sPESI scores for risk stratification in clinical practice, potentially influencing guidelines and policies on managing PTE. Further research into the HALP score's role in other contexts may refine its prognostic utility.

Evaluation of pan-Immuno-Inflammation value for In-hospital mortality in acute pulmonary embolism patients

Comparison of pan-immune-inflammation value with other inflammation markers of long-term survival after ST-segment elevation myocardial infarction

Perfusion index: could it be a new tool for early identification of pulmonary embolism severity?

Pleural effusion as an indicator of short term mortality in acute pulmonary embolism

The prognostic importance of the pan-immune-inflammation value in patients with septic shock

TIMI Risk Index As a Predictor of 30-Day Outcomes in Patients with Acute Pulmonary Embolism.

Can the pan-immune-inflammation value predict gram negative bloodstream infection-related 30-day mortality in solid organ transplant patients?

Prognostic Role of a New Risk Index for the Prediction of 30-Day Cardiovascular Mortality in Patients with Acute Pulmonary Embolism: the Age-Mean Arterial Pressure Index (AMAPI)

Prognostic Role of Serial Electrocardiographic Changes in Patients with Acute Pulmonary Embolism. Data from the Italian Pulmonary Embolism Registry

Platelet Indices in Assessment of in Hospital Mortality in Intensive Care Unit Patients

Evaluation of inflammatory biomarkers affecting mortality in acute cholecystitis in the emergency department

Pan-Immune-Inflammatory Value is Superior to Other Inflammatory Indicators in Predicting Inpatient Major Adverse Cardiovascular Events and Severe Coronary Artery Stenosis after Percutaneous Coronary Intervention in STEMI Patients

The prognostic value of HALP score and sPESI in predicting in-hospital mortality in patients with pulmonary thromboembolism

Can peripheral perfusion index predict disease mortality in COVID-19 patients in the emergency department

D-dimer/high sensitive troponin I ratio is useful in predicting in-hospital mortality in pulmonary embolism patients

Pan-Immune-Inflammatory Value Predicts the 3 Months Outcome in Acute Ischemic Stroke Patients after Intravenous Thrombolysis

Charlson and Elixhauser Comorbidity Indices for Prediction of Mortality and Hospital Readmission in Patients With Acute Pulmonary Embolism

Performance of the Simplified Pulmonary Embolism Severity Index in Predicting 30-Day Mortality after Acute Pulmonary Embolism: Validation from a Large-Scale Cohort.

Prognostic impact of pleural effusion in acute pulmonary embolism

Mortality Risk in Patients with Pulmonary Embolism with Pleural Effusion

Impact of Clinical Profile at Admission on the Outcomes in Patients Hospitalized for Acute Pulmonary Embolism: Data from the IPER Registry